Searched for
MODERNA VACCINE EFFICACY
US FDA approves Moderna's next-gen COVID vaccine for adults 65 or olderModerna's updated COVID-19 vaccine has received FDA approval for individuals aged 65 and older, marking the first endorsement under stricte...- Moderna's COVID vaccine is effective in children under 6, FDA saysThe FDA cautioned that estimates of the efficacy of Moderna's two-dose pediatric vaccine were based on relatively few cases of COVID-19. Th...
- Biological E to hold trials of its Covid vaccine as booster shotChristian Medical College (CMC), Vellore has said that it is conducting a study to test the efficacy of a booster dose on those who have re...
- Moderna says its COVID-19 shot remains 93% effective 4-6 months after second doseThat compares favorably to data released by rivals Pfizer Inc and BioNTech SE last week in which they suggested their vaccine's efficacy wa...
- Moderna vaccine to be available at select hospitals by Mid-JulyLast week, Indian’s drug regulator granted permission to Cipla to import donated doses of Moderna from the US. The vax doses, which are bei...
- Moderna Covid vaccine efficacy falls slightly to 90% in US trialA company press release did not indicate why efficacy has fallen, but one reason might be the emergence of new variants of concern which ar...
- COVID-19 vaccines in India in a nutshellThe Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a t...
- Coronavirus vaccine efficacy: What does it mean?Pfizer-Biontech and Moderna recently announced the first interim efficacy analysis of their Covid-19 vaccines. The financial markets cheere...
- Swiss drugs regulator approves Moderna’s COVID-19 vaccineSwitzerland has been a second-wave coronavirus hotspot, with infections totalling some 500,000 and deaths rising by dozens daily to more th...
- How does AstraZeneca's vaccine compare with Pfizer-BioNTech?Britain on Wednesday became the first country to approve AstraZeneca and Oxford University's home-grown UK COVID-19 vaccine, adding an easy...
- COVID-19: Moderna submits vaccine data to obtain emergency use authorisation"Moderna's data for the emergency use authorisation request for mRNA-1273 has been submitted to the US FDA," Moderna tweeted on Monday.
- Moderna to seek US, EU emergency authorization after COVID-19 vaccine 94.1% effectiveModerna also reported a 100% success rate in preventing severe cases. The filing sets Moderna's product up to be the second vaccine likely ...
- After varied efficacy data, AstraZeneca to conduct fresh clinical trials of COVID-19 vaccineAstraZeneca/Oxford said this week it would assess why its vaccine candidate generated better efficacy at a lower dose. The statement came a...
- AstraZeneca faces more vaccine questions after manufacturing errorWhile an announcement Monday by Astra and Oxford showed their shot was 70% effective on average in a late-stage study, the scant details re...
- 3 Covid vaccines’ efficacy higher than flu shotsAnthony Fauci, top infectious disease expert in the US, had said the over 90% efficacy of Pfizer vaccine candidate ‘is just extraordinary’ ...
- Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virusSpeaking in a briefing, Andrew Pollard, director of the Oxford Vaccine Group, said it is hard to explain the different efficacy rates betwe...
- Price of our Covid vaccine lower than Pfizer and Moderna's: Sputnik V Twitter account"Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of U...
- India in dialogue with Moderna, other biotech firms over progress in COVID vaccine development: SourcesModerna on Monday said the independent National Institutes of Health-appointed Data Safety Monitoring Board (DSMB) for the Phase 3 study of...
- India's likely to get access to Moderna's coronavirus vaccine via COVAX facilitySince Moderna received funding from the Coalition for Epidemic Preparedness Innovations (CEPI), which is a part of COVAX, India may get dos...
- Moderna closes in on release of COVID-19 vaccine dataModerna said the information is being prepared for submission to the trial's independent data safety monitoring board, which will look at t...
Load More
